168 related articles for article (PubMed ID: 37321224)
1. ROTACs leverage signaling-incompetent R-spondin for targeted protein degradation.
Sun R; Meng Z; Lee H; Offringa R; Niehrs C
Cell Chem Biol; 2023 Jul; 30(7):739-752.e8. PubMed ID: 37321224
[TBL] [Abstract][Full Text] [Related]
2. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin.
Zebisch M; Xu Y; Krastev C; MacDonald BT; Chen M; Gilbert RJ; He X; Jones EY
Nat Commun; 2013; 4():2787. PubMed ID: 24225776
[TBL] [Abstract][Full Text] [Related]
3. LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43/ZNRF3 to provide high affinity binding of R-spondin ligands.
Toh Y; Wu L; Park S; Wang A; Tu J; Yu W; Zuo M; Carmon KS; Liu QJ
Sci Rep; 2023 Jul; 13(1):10796. PubMed ID: 37402772
[TBL] [Abstract][Full Text] [Related]
4. Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1.
Cotton AD; Nguyen DP; Gramespacher JA; Seiple IB; Wells JA
J Am Chem Soc; 2021 Jan; 143(2):593-598. PubMed ID: 33395526
[TBL] [Abstract][Full Text] [Related]
5. Roadmap for Optimizing and Broadening Antibody-Based PROTACs for Degradation of Cell Surface Proteins.
Gramespacher JA; Cotton AD; Burroughs PWW; Seiple IB; Wells JA
ACS Chem Biol; 2022 May; 17(5):1259-1268. PubMed ID: 35481357
[TBL] [Abstract][Full Text] [Related]
6. Interaction with both ZNRF3 and LGR4 is required for the signalling activity of R-spondin.
Xie Y; Zamponi R; Charlat O; Ramones M; Swalley S; Jiang X; Rivera D; Tschantz W; Lu B; Quinn L; Dimitri C; Parker J; Jeffery D; Wilcox SK; Watrobka M; LeMotte P; Granda B; Porter JA; Myer VE; Loew A; Cong F
EMBO Rep; 2013 Dec; 14(12):1120-6. PubMed ID: 24165923
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of R-spondin:LGR4:ZNRF3 adult stem cell growth factor signaling complexes with recombinant proteins produced in Escherichia coli.
Moad HE; Pioszak AA
Biochemistry; 2013 Oct; 52(41):7295-304. PubMed ID: 24050775
[TBL] [Abstract][Full Text] [Related]
8. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling.
Giebel N; de Jaime-Soguero A; García Del Arco A; Landry JJM; Tietje M; Villacorta L; Benes V; Fernández-Sáiz V; Acebrón SP
EMBO Rep; 2021 May; 22(5):e51415. PubMed ID: 33786993
[TBL] [Abstract][Full Text] [Related]
9. Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression.
Wang K; Dai X; Yu A; Feng C; Liu K; Huang L
J Exp Clin Cancer Res; 2022 Sep; 41(1):289. PubMed ID: 36171633
[TBL] [Abstract][Full Text] [Related]
10. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.
Hao HX; Xie Y; Zhang Y; Charlat O; Oster E; Avello M; Lei H; Mickanin C; Liu D; Ruffner H; Mao X; Ma Q; Zamponi R; Bouwmeester T; Finan PM; Kirschner MW; Porter JA; Serluca FC; Cong F
Nature; 2012 Apr; 485(7397):195-200. PubMed ID: 22575959
[TBL] [Abstract][Full Text] [Related]
11. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases.
Jiang X; Charlat O; Zamponi R; Yang Y; Cong F
Mol Cell; 2015 May; 58(3):522-33. PubMed ID: 25891077
[TBL] [Abstract][Full Text] [Related]
12. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength.
de Lau W; Peng WC; Gros P; Clevers H
Genes Dev; 2014 Feb; 28(4):305-16. PubMed ID: 24532711
[TBL] [Abstract][Full Text] [Related]
13. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer.
Hao HX; Jiang X; Cong F
Cancers (Basel); 2016 Jun; 8(6):. PubMed ID: 27338477
[TBL] [Abstract][Full Text] [Related]
14. Receptor control by membrane-tethered ubiquitin ligases in development and tissue homeostasis.
Lebensohn AM; Bazan JF; Rohatgi R
Curr Top Dev Biol; 2022; 150():25-89. PubMed ID: 35817504
[TBL] [Abstract][Full Text] [Related]
15. The structural basis of R-spondin recognition by LGR5 and RNF43.
Chen PH; Chen X; Lin Z; Fang D; He X
Genes Dev; 2013 Jun; 27(12):1345-50. PubMed ID: 23756651
[TBL] [Abstract][Full Text] [Related]
16. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling.
Peng WC; de Lau W; Madoori PK; Forneris F; Granneman JC; Clevers H; Gros P
PLoS One; 2013; 8(12):e83110. PubMed ID: 24349440
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of R-spondin 2 in complex with the ectodomains of its receptors LGR5 and ZNRF3.
Zebisch M; Jones EY
J Struct Biol; 2015 Aug; 191(2):149-55. PubMed ID: 26123262
[TBL] [Abstract][Full Text] [Related]
18. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.
Koo BK; Spit M; Jordens I; Low TY; Stange DE; van de Wetering M; van Es JH; Mohammed S; Heck AJ; Maurice MM; Clevers H
Nature; 2012 Aug; 488(7413):665-9. PubMed ID: 22895187
[TBL] [Abstract][Full Text] [Related]
19. Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox.
Siepe DH; Picton LK; Garcia KC
ACS Synth Biol; 2023 Apr; 12(4):1081-1093. PubMed ID: 37011906
[TBL] [Abstract][Full Text] [Related]
20. Targeted Degradation of PD-L1 and Activation of the STING Pathway by Carbon-Dot-Based PROTACs for Cancer Immunotherapy.
Su W; Tan M; Wang Z; Zhang J; Huang W; Song H; Wang X; Ran H; Gao Y; Nie G; Wang H
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202218128. PubMed ID: 36647763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
